202 related articles for article (PubMed ID: 20975072)
21. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
Neppelenbroek SIM; Geurts YM; Aleman BMP; Lugtenburg PJ; Rademakers SE; de Weijer RJ; Schippers MGA; Ta BDP; Plattel WJ; Zijlstra JM; van der Maazen RWM; Nijziel MR; Ong F; Schimmel EC; Posthuma EFM; Kersten MJ; Böhmer LH; Muller K; Koene HR; Te Boome LCJ; Bilgin YM; de Jongh E; Janus CPM; van Leeuwen FE; Schaapveld M
J Clin Oncol; 2024 Jun; 42(16):1903-1913. PubMed ID: 38359378
[TBL] [Abstract][Full Text] [Related]
22. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
[TBL] [Abstract][Full Text] [Related]
23. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
Chowdhry AK; Fung C; Chowdhry VK; Bergsma D; Dhakal S; Constine LS; Milano MT
Leuk Lymphoma; 2018 May; 59(5):1180-1187. PubMed ID: 28862484
[TBL] [Abstract][Full Text] [Related]
24. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
25. Racial and Ethnic Disparities in the Pediatric Hodgkin Lymphoma Population.
Grubb WR; Neboori HJ; Diaz AD; Li H; Kwon D; Panoff J
Pediatr Blood Cancer; 2016 Mar; 63(3):428-35. PubMed ID: 26524117
[TBL] [Abstract][Full Text] [Related]
26. Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.
Horst KC; Hancock SL; Ognibene G; Chen C; Advani RH; Rosenberg SA; Donaldson SS; Hoppe RT
Ann Oncol; 2014 Apr; 25(4):848-851. PubMed ID: 24608191
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.
Minn AY; Riedel E; Halpern J; Johnston LJ; Horning SJ; Hoppe RT; Goodman KA
Br J Haematol; 2012 Nov; 159(3):329-39. PubMed ID: 22966754
[TBL] [Abstract][Full Text] [Related]
28. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
29. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
30. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients.
Yahalom J; Petrek JA; Biddinger PW; Kessler S; Dershaw DD; McCormick B; Osborne MP; Kinne DA; Rosen PP
J Clin Oncol; 1992 Nov; 10(11):1674-81. PubMed ID: 1403050
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
35. The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.
Howell SJ; Searle C; Goode V; Gardener T; Linton K; Cowan RA; Harris MA; Hopwood P; Swindell R; Norman A; Kennedy J; Howell A; Wardley AM; Radford JA
Br J Cancer; 2009 Aug; 101(4):582-8. PubMed ID: 19672261
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
37. Risk of male breast cancer after Hodgkin lymphoma.
de Vries S; Krul IM; Schaapveld M; Janus CPM; Rademakers SE; Roesink JM; Nijziel MR; Bilgin YM; Aleman BMP; van Leeuwen FE
Blood; 2023 Aug; 142(9):806-811. PubMed ID: 37390297
[TBL] [Abstract][Full Text] [Related]
38. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
Lin L; Wang D; Chen H
PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
[TBL] [Abstract][Full Text] [Related]
39. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
[TBL] [Abstract][Full Text] [Related]
40. Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and Adolescence.
Dörffel W; Riepenhausenl M; Lüders H; Brämswig J; Schellong G
Dtsch Arztebl Int; 2015 May; 112(18):320-7, i. PubMed ID: 26037468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
